首页> 外文OA文献 >Thromboxane A2 receptor and MaxiK-channel intimate interaction supports channel trans-inhibition independent of G-protein activation
【2h】

Thromboxane A2 receptor and MaxiK-channel intimate interaction supports channel trans-inhibition independent of G-protein activation

机译:血栓烷A2受体和MaxiK通道紧密相互作用支持独立于G蛋白激活的通道反式抑制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Large conductance voltage- and calcium-activated potassium channels (MaxiK, BKCa) are well known for sustaining cerebral and coronary arterial tone and for their linkage to vasodilator β-adrenergic receptors. However, how MaxiK channels are linked to counterbalancing vasoconstrictor receptors is unknown. Here, we show that vasopressive thromboxane A2 receptors (TP) can intimately couple with and inhibit MaxiK channels. Activation of the receptor with its agonist trans-inhibits MaxiK independently of G-protein activation. This unconventional mechanism is supported by independent lines of evidence: (i) inhibition of MaxiK current by thromboxane A2 mimetic, U46619, occurs even when G-protein activity is suppressed; (ii) MaxiK and TP physically associate and display a high degree of proximity; and (iii) Förster resonance energy transfer occurs between fluorescently labeled MaxiK and TP, supporting a direct interaction. The molecular mechanism of MaxiK–TP intimate interaction involves the receptor's first intracellular loop and C terminus, and it entails the voltage-sensing conduction cassette of MaxiK channel. Further, physiological evidence of MaxiK–TP physical interaction is given in human coronaries and rat aorta, and by confirming TP role (with antagonist SQ29,548) in the U46619-induced MaxiK inhibition in human coronaries. We propose that vasoconstrictor TP receptor and MaxiK-channel direct interaction facilitates G-protein–independent TP to MaxiK trans-inhibition, which would promote vasoconstriction.
机译:众所周知,大的电导电压和钙激活钾离子通道(MaxiK,BKCa)能够维持脑和冠状动脉的张力,并与血管扩张剂β-肾上腺素受体相连。但是,MaxiK通道如何与平衡的血管收缩受体连接是未知的。在这里,我们显示血管抑制性血栓烷A2受体(TP)可以与MaxiK通道紧密耦合并抑制它们。受体及其激动剂的激活反过来抑制MaxiK,而与G蛋白激活无关。这种非常规的机制由独立的证据支持:(i)即使抑制了G蛋白活性,血栓素A2模拟物U46619对MaxiK电流的抑制作用也会发生; (ii)MaxiK和TP物理关联并显示高度接近度; (iii)福斯特共振能量转移发生在荧光标记的MaxiK和TP之间,支持直接相互作用。 MaxiK–TP紧密相互作用的分子机制涉及受体的第一个细胞内环和C末端,并且需要MaxiK通道的电压感应传导盒。此外,在人冠状动脉和大鼠主动脉中提供了MaxiK-TP物理相互作用的生理学证据,并证实了TP在U46619诱导的人冠状动脉抑制中的作用(与拮抗剂SQ29,548)。我们建议血管收缩TP受体和MaxiK通道直接相互作用促进G蛋白非依赖性TP到MaxiK反式抑制,这将促进血管收缩。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号